265 related articles for article (PubMed ID: 37417594)
1. Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.
Zheng W; Wu Y; Wang Y; Cheng J; Shen W
Medicine (Baltimore); 2023 Jul; 102(27):e34228. PubMed ID: 37417594
[TBL] [Abstract][Full Text] [Related]
2. An evidence mapping and scientometric analysis of the top-100 most cited clinical trials of anti-PD-1/PD-L1 drugs to treat cancers.
Liu M; Gao Y; Yuan Y; Shi S; Wu J; Tian J; Zhang J
Biomed Pharmacother; 2021 Nov; 143():112238. PubMed ID: 34649362
[TBL] [Abstract][Full Text] [Related]
3. Top 100 most-cited articles on renal cell carcinoma: A bibliometric analysis.
Zhou H; Cui F; Lv D; Gong Q; Wen J; Shuang W
Medicine (Baltimore); 2023 Feb; 102(6):e32926. PubMed ID: 36820552
[TBL] [Abstract][Full Text] [Related]
4. The Top 100 Most Frequently Cited Publications Concerning Anti-PD-1/PD-L1 Therapy for Lung Cancer: A Bibliometric Analysis.
Li Y; Lv M; Liu J; Ma J; Liang M; Zheng N
Cancer Manag Res; 2021; 13():1383-1393. PubMed ID: 33613031
[TBL] [Abstract][Full Text] [Related]
5. The top 100 highly cited articles on anterior cruciate ligament from 2000 to 2019: A bibliometric and visualized analysis.
Zhu Y; Zhang C; Wang J; Xie Y; Wang L; Xu F
Orthop Traumatol Surg Res; 2021 Dec; 107(8):102988. PubMed ID: 34146752
[TBL] [Abstract][Full Text] [Related]
6. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
7. Evolutions in the management of non-small cell lung cancer: A bibliometric study from the 100 most impactful articles in the field.
Chen S; Qiao Y; Chen J; Li Y; Xie J; Cui P; Huang Z; Huang D; Gao Y; Hu Y; Liu Z
Front Oncol; 2022; 12():939838. PubMed ID: 36059661
[TBL] [Abstract][Full Text] [Related]
8. The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia.
Zhong Q; Li BH; Zhu QQ; Zhang ZM; Zou ZH; Jin YH
Front Pharmacol; 2019; 10():1100. PubMed ID: 31611792
[No Abstract] [Full Text] [Related]
9. A bibliometric study of the nasopharyngeal cancer immunotherapy knowledge map.
Xie H; Liu W; Yang M
Medicine (Baltimore); 2024 Apr; 103(16):e37763. PubMed ID: 38640273
[TBL] [Abstract][Full Text] [Related]
10. Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis.
Liu Y; Xu Y; Cheng X; Lin Y; Jiang S; Yu H; Zhang Z; Lu L; Zhang X
Front Immunol; 2022; 13():862084. PubMed ID: 35493449
[TBL] [Abstract][Full Text] [Related]
11. Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
Su Y; Ruan Z; Wang R; Hao S; Tang Y; Huang X; Gao T; Li Z; Chang T
Front Immunol; 2022; 13():998217. PubMed ID: 36248874
[TBL] [Abstract][Full Text] [Related]
12. The Top-Cited Original Articles on the Role of Microglia in Neurodegenerative Diseases: A Bibliometric and Visualized Study.
Sun M; Li X; Sun J; Wang H; Xie Q; Wang M
Front Aging Neurosci; 2022; 14():869964. PubMed ID: 35478696
[TBL] [Abstract][Full Text] [Related]
13. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
[TBL] [Abstract][Full Text] [Related]
14. Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022).
Huang X; Guo J; Wang S; Lin Z; Zhao S; Li W; Wang Y; Zhu C; Lv J; Qiu W
Hum Vaccin Immunother; 2023 Aug; 19(2):2246498. PubMed ID: 37635349
[TBL] [Abstract][Full Text] [Related]
15. Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023).
Song L; Liang X; Zhu M; Su Q; Li F
Front Immunol; 2023; 14():1328103. PubMed ID: 38264659
[TBL] [Abstract][Full Text] [Related]
16. The top 100 most cited papers on endometrial carcinoma: A bibliometric analysis.
Xiao P; Yao C; Wang G
Front Oncol; 2022; 12():987980. PubMed ID: 36059668
[TBL] [Abstract][Full Text] [Related]
17. Top 100 cited articles in the thromboangiitis obliterans: a bibliometric analysis and visualized study.
Liu Z; Ning W; Liang J; Zhang T; Yang Q; Zhang J; Xie M
Eur J Med Res; 2023 Dec; 28(1):551. PubMed ID: 38042838
[TBL] [Abstract][Full Text] [Related]
18. Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis.
Yang Y; Wang F
Front Oncol; 2022; 12():983892. PubMed ID: 36465399
[TBL] [Abstract][Full Text] [Related]
19. Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.
Liu YG; Jiang ST; Zhang L; Zheng H; Zhang T; Zhang JW; Zhao HT; Sang XT; Xu YY; Lu X
Eur J Med Res; 2023 Jul; 28(1):229. PubMed ID: 37430294
[TBL] [Abstract][Full Text] [Related]
20. Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis.
Ou L; Su C; Liang L; Duan Q; Li Y; Zang H; He Y; Zeng R; Li Y; Zhou H; Xiao L
Hum Vaccin Immunother; 2023 Dec; 19(3):2267865. PubMed ID: 37846106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
